In vitro bioassays reveal potent antioxidant, antileishmanial, and antidiabetic properties in Fabaceae plant extracts, highlighting their potential for developing novel antimicrobial and metabolic...
Introduction: The increasing prevalence of chronic diseases and infectious ailments necessitates the exploration of novel therapeutic agents. This study aims to elucidate selected Fabaceae species’ phytochemical composition and biological activities. Methods: Antioxidant potential was assessed with the DPPH assay, while DNA protection and antidiabetic activity were tested via inhibition assays. Anti-leishmanial and anti-dengue potentials were evaluated against Leishmania major and Aedes aegypti. Results: Sophora mollis, Mucuna pruriens, and Sesbania sesbans exhibited the highest phytochemical content. The DPPH-scavenging power of M. pruriens was highest (14.09 ± 3.60 µg/ml), and the DNA protection ability of P. tuberosa methanol extracts was highest. The methanol extract of S. sesbans effectively inhibited leishmaniasis (82.99 % inhibition) and dengue (70.10 ppm LD50). GC/MS identified 37 compounds, with 9-octadecenamide (Z) and tetradecanamide predominating. Conclusion: The methanol leaves extracts of selected Fabaceae species revealed significant biological properties compared to the methanol-DMSO and methanol-glycerol extracts. Furthermore, carrying out the synergistic effects of antileishmanial, anti-dengue, antidiabetic, and antioxidant compounds, may lead to the development of more effective and comprehensive therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Safdar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: